Tamoxifen treatment of breast cancer cells : Impact on Hedgehog/GLI1 signaling
The selective estrogen receptor (ER) modulator tamoxifen (TAM) has become the standard therapy for the treatment of ER+ breast cancer patients. Despite the obvious benefits of TAM, a proportion of patients acquire resistance to treatment, and this is a significant clinical problem. Consequently, the...
Autores Principales: | , , , , , , |
---|---|
Formato: | Artículo (Article) |
Lenguaje: | Inglés (English) |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/21353 https://doi.org/10.3390/ijms17030308 |